Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year
Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down
More Bad News for AVEO As Tivozanib Partner Bids Adieu
ASCO to Present 2013 Special Awards at Annual Meeting
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO